[Radiation therapy in the extranodal non-Hodgkin's lymphoma of the maxillo-facial region].
An analysis was made on localized extranodal non-Hodgkin's lymphoma in the maxillo-facial region treated with radiation. Histopathological evaluation was reviewed by Rappaport classification and Working Formulation (WF). High grade histology of WF was rather frequent (32%) compared to Waldeyer's (NHL) (7%). Prognosis of the disease was highly influenced by histopathologic grade in WF; five-year survival rate was 100% with low grade, 65.6% with intermediate grade and 33.3% with high grade. Marginal relapse was rare after radiation dose of 30-50 Gy, however, there was a high incidence of bone and/or soft tissue relapses. Bone marrow biopsy and bone scintigram were useful examinations in the staging procedure of extranodal NHL.
Horiuchi
J
J
Dept. of Radiology, Tokyo Med. & Dent. Univ.
Shibya
H
H
Matsumoto
S
S
Kamiyama
R
R
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000453:epidemiology / Q000556:secondary; D001842:Bone and Bones / Q000000981:diagnostic imaging; D005153:Facial Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007564:Japan; D008198:Lymph Nodes; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009367:Neoplasm Staging; D009669:Nose Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D011877:Radionuclide Imaging; D011879:Radiotherapy Dosage; D012983:Soft Tissue Neoplasms / Q000453:epidemiology / Q000556:secondary